Vasopressin receptor antagonists in heart failure

Author： Thibonnier M.  

Publisher： Elsevier

ISSN： 1471-4892

Source： Current Opinion in Pharmacology, Vol.3, Iss.6, 2003-12, pp. : 683-687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vasopressin receptor antagonists in the management of acute heart failure

By Tang WH Wilson   Bhavnani Sanjeev   Francis Gary S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D.   DeWald T.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

The therapeutic potential of vasopressin receptor antagonists in congestive heart failure

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 687-691

Informa Healthcare

Access to resources Recommend Favorite

Heart failure and endothelin receptor antagonists

By Miyauchi T.   Goto K.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 210-217

Elsevier

Access to resources Recommend Favorite

Is vasopressin-receptor antagonism an advancement in the treatment of heart failure?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2181-2184

Informa Healthcare

Access to resources Recommend Favorite